Maxime Verhoeven

53 An indirect comparison of treat-to-target strategies in early RA 19. Kay, J. et al. Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year. Arthritis Res. Ther. 16 , R40 (2014). 20. Mcinnes, I. B. & Schett, G. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 365 , 2205– 2219 (2011). 21. Nishimoto, N. & Mima, T. CHAPTER 10J - Tocilizumab. in Rheumatoid Arthritis . 367–371 (2009). 22. van Nies, J. A. B., Tsonaka, R., Fautrel, B. & van Mil-van der Helm, A. H. M. Evaluating relationships between symptom duration and persistence of rheumatoid arthritis: does a window of opportunity exist ? Results on the Leiden early arthritis clinic and ESPOIR cohorts. Ann. Rheum. Dis. 74 , 806–812 (2015). 23. Felson, D. T. et al. American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum. 63 , 573–586 (2011). 3